Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2010

01-12-2010 | Research Report

Past, present and future of newborn screening in Chile

Authors: V. Cornejo, E. Raimann, J. F. Cabello, A. Valiente, C. Becerra, M. Opazo, M. Colombo

Published in: Journal of Inherited Metabolic Disease | Special Issue 3/2010

Login to get access

Abstract

The history of the Newborn Screening Program in Chile begins in 1984, when a pilot plan was developed that demonstrated the feasibility of its implementation. In 1992, the Ministry of Health started a national newborn screening program for phenylketonuria (PKU) and congenital hypothyroidism (CH), and in 1998, this was extended to the entire country. Throughout this period, a total of 2,478,123 newborns (NB) have been analyzed, obtaining initial coverage of 48.8%, which was later increased to 87.7%, and at present it is at 98.7% of all NB of our country. During this period, 131 cases with PKU have been diagnosed, resulting in an incidence of 1:18,916 NB, an average age of diagnosis of 18 ± 10.2 days and average phenylalanine level of 19,9 ± 8.8 mg/dl. In relation to CH, 783 cases have been confirmed, arriving at an incidence of 1:3,163 NB, with average age of diagnosis of 12.5 ± 6.9 days. Due to the good results of the program, the government is evaluating the initiation of an extended pilot program, to introduce other pathologies.
Literature
go back to reference American Academy of Pediatrics, Committee on Genetics (1992) Issues in newborn screening. Pediatrics 89:345–349 American Academy of Pediatrics, Committee on Genetics (1992) Issues in newborn screening. Pediatrics 89:345–349
go back to reference American Academy of Pediatrics Newborn Screening Authoring Committee (2008) Newborn screening expands: recommendations for pediatricians and medical homes implications for the system. Pediatrics 121:192–217CrossRef American Academy of Pediatrics Newborn Screening Authoring Committee (2008) Newborn screening expands: recommendations for pediatricians and medical homes implications for the system. Pediatrics 121:192–217CrossRef
go back to reference Bodamer OA, Hoffmann GF, Lindner M (2007) Expanded newborn screening in Europe 2007. J Inherit Metab Dis 30:439–444PubMedCrossRef Bodamer OA, Hoffmann GF, Lindner M (2007) Expanded newborn screening in Europe 2007. J Inherit Metab Dis 30:439–444PubMedCrossRef
go back to reference Borrajo G (2007) Newborn screening in Latin America at the beginning of the 21st century. J Inherit Metab Dis 30:466–481PubMedCrossRef Borrajo G (2007) Newborn screening in Latin America at the beginning of the 21st century. J Inherit Metab Dis 30:466–481PubMedCrossRef
go back to reference Centers for Disease Control and Prevention (CDC) (2008) Impact of expanded newborn screening–United States, 2006. Morb Mortal Wkly Rep 57:1012–1015 Centers for Disease Control and Prevention (CDC) (2008) Impact of expanded newborn screening–United States, 2006. Morb Mortal Wkly Rep 57:1012–1015
go back to reference Colombo M, Troncoso L, Raimann E, Perales CG, Barros T, Cornejo V (1988) Diagnóstico de Fenilquetonuria en Chile. Rev Chil Pediatr 59:235–239PubMedCrossRef Colombo M, Troncoso L, Raimann E, Perales CG, Barros T, Cornejo V (1988) Diagnóstico de Fenilquetonuria en Chile. Rev Chil Pediatr 59:235–239PubMedCrossRef
go back to reference Cornejo V, Colombo M (1986) Diagnóstico precoz de fenilquetonuria y prevención de retardo mental. In: Cornejo V, Colombo M (eds) Tesis para optar al grado de Magister en Nutrición Humana INTA. Universidad de Chile, Santiago, Chile, pp 1–67 Cornejo V, Colombo M (1986) Diagnóstico precoz de fenilquetonuria y prevención de retardo mental. In: Cornejo V, Colombo M (eds) Tesis para optar al grado de Magister en Nutrición Humana INTA. Universidad de Chile, Santiago, Chile, pp 1–67
go back to reference Cornejo V, Raimann E, Moraga M, Colombo M (1990) Programa de rastreo neonatal de fenilquetonuria. Rev Chil Pediatr 61:309–312PubMed Cornejo V, Raimann E, Moraga M, Colombo M (1990) Programa de rastreo neonatal de fenilquetonuria. Rev Chil Pediatr 61:309–312PubMed
go back to reference Cornejo V, Colombo M, Durán G et al (2002) Diagnosis and follow up of 23 children with organic acidurias. Rev Med Chile 130:259–266PubMed Cornejo V, Colombo M, Durán G et al (2002) Diagnosis and follow up of 23 children with organic acidurias. Rev Med Chile 130:259–266PubMed
go back to reference Cornejo V, Raimann E, Colombo M (2003) Implementación y desarrollo de los programas de detección neonatal., In Colombo M, Cornejo, E., Raimann, E (eds). Errores innatos en el metabolismo del niño, Universitaria, 375-384. Cornejo V, Raimann E, Colombo M (2003) Implementación y desarrollo de los programas de detección neonatal., In Colombo M, Cornejo, E., Raimann, E (eds). Errores innatos en el metabolismo del niño, Universitaria, 375-384.
go back to reference Cornejo V, et al (2007) Normas para el óptimo desarrollo de programas de búsqueda masiva de Fenilquetonuria (PKU), e Hipotiroidismo Congénito (HC) y otros errores congénitos del metabolismo. Editorial Ministerio de Salud, División de Prevención y Control de Enfermedades, República de Chile. Norma general técnica nº 93, 1-59. Cornejo V, et al (2007) Normas para el óptimo desarrollo de programas de búsqueda masiva de Fenilquetonuria (PKU), e Hipotiroidismo Congénito (HC) y otros errores congénitos del metabolismo. Editorial Ministerio de Salud, División de Prevención y Control de Enfermedades, República de Chile. Norma general técnica nº 93, 1-59.
go back to reference Cuello X, Pérez P, Vivanco X, Lobo G, Bruggendiek B, Pérez A (2004) Evaluación de 7 años de programa nacional de detección precoz de hipotiroidismo congénito en Chile. Bol Hosp San Juan de Dios 51:221–230 Cuello X, Pérez P, Vivanco X, Lobo G, Bruggendiek B, Pérez A (2004) Evaluación de 7 años de programa nacional de detección precoz de hipotiroidismo congénito en Chile. Bol Hosp San Juan de Dios 51:221–230
go back to reference Dietzen DJ, Rinaldo P, Whitley RJ et al (2009) National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summary. Clin Chem 55:1615–1626PubMedCrossRef Dietzen DJ, Rinaldo P, Whitley RJ et al (2009) National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summary. Clin Chem 55:1615–1626PubMedCrossRef
go back to reference Frazier DM, Millington DS, McCandless SE et al (2006) The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis 29:76–85PubMedCrossRef Frazier DM, Millington DS, McCandless SE et al (2006) The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis 29:76–85PubMedCrossRef
go back to reference la Marca G, Malvagia S, Pasquini E et al (2008) The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs. Rapid Commun Mass Spectrom 22:812–818PubMedCrossRef la Marca G, Malvagia S, Pasquini E et al (2008) The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs. Rapid Commun Mass Spectrom 22:812–818PubMedCrossRef
go back to reference de Salud M, de Chile G (2005) Documentos, Ley 19.966: régimen general de garantías de salud. Rev Chil Obstet Ginecol 70:119–129 de Salud M, de Chile G (2005) Documentos, Ley 19.966: régimen general de garantías de salud. Rev Chil Obstet Ginecol 70:119–129
go back to reference Schulze A, Linder M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann G (2003) Expanded newborn screening for inborn errors of metabolism by electrospary ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111:1399–1406PubMedCrossRef Schulze A, Linder M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann G (2003) Expanded newborn screening for inborn errors of metabolism by electrospary ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111:1399–1406PubMedCrossRef
go back to reference Therrell BL, Hannon WH (2006) National evaluation of US newborn screening system components. Ment Retard Dev Disabil Res Rev 12:236–245PubMedCrossRef Therrell BL, Hannon WH (2006) National evaluation of US newborn screening system components. Ment Retard Dev Disabil Res Rev 12:236–245PubMedCrossRef
go back to reference Wilcken B, Webster D (1991) Neonatal screening in the nineties. In: Wilcken B (ed) International Neonatal Screening Symposium. Excepta Médica, Sydney Australia, p 372 Wilcken B, Webster D (1991) Neonatal screening in the nineties. In: Wilcken B (ed) International Neonatal Screening Symposium. Excepta Médica, Sydney Australia, p 372
go back to reference Wilcken B, Haas M, Joy P et al (2009) Expanded newborn screening: outcome in screened and unscreened patients at age 6 years. Pediatrics 124:241–248CrossRef Wilcken B, Haas M, Joy P et al (2009) Expanded newborn screening: outcome in screened and unscreened patients at age 6 years. Pediatrics 124:241–248CrossRef
go back to reference Wilcken B (2008) The consequences of extended newborn screening programmes: do we know who needs treatment? J Inherit Metab Dis 31:173–177PubMedCrossRef Wilcken B (2008) The consequences of extended newborn screening programmes: do we know who needs treatment? J Inherit Metab Dis 31:173–177PubMedCrossRef
Metadata
Title
Past, present and future of newborn screening in Chile
Authors
V. Cornejo
E. Raimann
J. F. Cabello
A. Valiente
C. Becerra
M. Opazo
M. Colombo
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue Special Issue 3/2010
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9165-8

Other articles of this Special Issue 3/2010

Journal of Inherited Metabolic Disease 3/2010 Go to the issue